PGEN
Precigen, Inc.
A biopharmaceutical company in Germantown, Maryland, that develops precision medicines for cancer, autoimmune disorders, and infectious diseases. It grew out of Intrexon, a synthetic biology firm founded in 1998, and in 2020 the whole company rebranded as Precigen to focus entirely on human health. Its name blends "precision" and "genetics," and its UltraCAR-T platform can engineer a patient's own immune cells overnight at the hospital using a non-viral "Sleeping Beauty" gene-delivery system.
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$108.51M
Total Shares
19.04M
Net Share Change
+1.22M
Activity
1 buying
Investor
Value
Shares
Weight
Change
